They made the transfers to life science companies like Lumen Bioscience Inc. and Platform Life Sciences Inc. under the guise of effective altruism, a philosophy espousing the transfer of wealth from affluent individuals to those in financial need, the filing shows. But, helping the less fortunate wasn’t the charitable arms true purpose, the firms’ lawyers said.
